# An Open-Label Study Of Lamictal In Neurotic Excoriation

> **NCT00269594** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 25 (actual)

## Conditions studied

- Neurotic Disorders
- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** Lamictal (lamotrigine)

## Key facts

- **NCT ID:** NCT00269594
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2007-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00269594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00269594, "An Open-Label Study Of Lamictal In Neurotic Excoriation". Retrieved via MORVS 2026-10-30 from https://api.morvs.ai/clinical/NCT00269594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*